Sabril vigabatrin neurology data

Lundbeck reported 3-year data from its registry of 4,292 patients with refractory complex partial seizures and infantile spasms receiving Sabril. Specifically, 2,339 (55%) patients discontinued Sabril treatment, of which 14 (0.6%) discontinued due

Read the full 338 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE